144750-52-7,
Clopidogrel Related Compound B,
methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetate hydrochloride,
AK159403,
CTK8E8616,
DTXSID80675775,
MFCD22375692,
SC1416,
AKOS024464097,
TRA0071926,
AC-24407,
AX8221118,
RT-012073,
4CH-019929,
FT-0665129,
ST24047607,
J-008005,
Clopidogrel Related Compound B, United States Pharmacopeia (USP) Reference Standard,
Methyl (+/-)-(o-Chlorophenyl)-4,5-dihydrothieno[3,2-c]pyridine-6(7H)acetate Hydrochloride,
Methyl (2RS)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate hydrochloride,
a-(2-chlorophenyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-acetic acid methyl ester hydrochloride,
Methyl (2-chlorophenyl)(4,7-dihydrothieno[2,3-c]pyridin-6(5H)-yl)acetate--hydrogen chloride (1/1),
methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridine-6(7H)-yl)acetate hydrochloride,
methyl 2-(2-chlorophenyl)-2-(5,7-dihydro-4H-thieno[2,3-c]pyridin-6-yl)acetate;hydrochloride,
Thieno[2,3-c]pyridine-6(5H)-acetic acid, alpha-(2-chlorophenyl)-4,7-dihydro-, methyl ester, hydrochloride (1:1),
Clopidogrel EP Impurity B,
SYAKRIYLSOOCKW-UHFFFAOYSA-N,
CS-O-07682,
BC658548,
methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetate hcl,
-(2-CHLOROPHENYL)-4,7-DIHYDRO-THIENO[2,3-C]PYRIDINE-6(5H)-ACETIC ACID METHYL ESTER HCL,
?-(2-CHLOROPHENYL)-4,7-DIHYDRO-THIENO[2,3-C]PYRIDINE-6(5H)-ACETIC ACID METHYL ESTER HCL,
|A-(2-Chlorophenyl)-4,7-dihydro-thieno[2,3-c]pyridine-6(5H)acetic Acid Methyl Ester Hydrochloride,